Seeing Is Believing
with an average price target of $0.11. This is a potential upside of $0.11 (0%) from yesterday's end of day stock price of $0.
Eidos Therapeutics's activity chart (see below) currently has 20 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 94.4 days.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 29-Dec-2020. First documented stock forecast 16-Jul-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$129
$6.79 (5.56%)
$73.26
4 years 11 months 17 days ago
(29-Dec-2020)
2/2 (100%)
$4.39 (3.52%)
1
Hold
$73.26
$-48.95 (-40.05%)
$80
5 years 2 months 11 days ago
(05-Oct-2020)
3/3 (100%)
$-0.25 (-0.34%)
128
Hold
$59
$-63.21 (-51.72%)
$59
5 years 2 months 11 days ago
(05-Oct-2020)
2/3 (66.67%)
$-14.51 (-19.74%)
84
Sell
$45
5 years 7 months 5 days ago
(11-May-2020)
1/2 (50%)
$-6 (-11.76%)
22
Hold
$29
6 years 9 months 19 days ago
(27-Feb-2019)
2/2 (100%)
$16.9 (139.67%)
237
What is EIDX (Eidos Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on EIDX (Eidos Therapeutics) with a proven track record?
Which analyst has the current lower performing score on EIDX (Eidos Therapeutics) with a proven track record?
Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?
Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?
Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?